文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

利用定植理解中低收入国家的抗菌药物耐药负担

Using Colonization to Understand the Burden of Antimicrobial Resistance Across Low- and Middle-Income Countries.
PubMed 文献 · Clin Infect Dis · 2023-01-01

全球抗菌药物耐药负担因监测不完整而难以评估,尤其在资源有限地区。美国疾病控制与预防中心支持的抗菌药物耐药社区与医院(ARCH)联盟覆盖6个资源有限地区,通过社区和医院层面的定植患病率刻画耐药负担并评估定植相关危险因素。本增刊7篇文章报告了这些初始研究的结果。

要点

  • 抗菌药物耐药负担的全球评估受监测不完整限制,在资源有限地区尤为突出。
  • ARCH联盟覆盖6个资源有限地区,在社区和医院层面调查定植患病率并评估相关危险因素。
  • 本增刊7篇文章报告了这些初始研究的结果。

核心结论

  • ARCH联盟的初始研究结果回答了抗菌药物耐药流行病学的重要问题。
  • 未来识别和评估预防策略的研究对减缓耐药传播及其对人群的影响至关重要。

研究设计与样本

  • ARCH联盟由美国疾病控制与预防中心支持,覆盖6个资源有限地区的多个站点。
  • 研究通过社区和医院层面的定植患病率刻画抗菌药物耐药负担,并评估与定植相关的危险因素。
  • 本增刊收录7篇文章,报告这些初始研究的结果。

主要发现

  • 本增刊7篇文章报告了ARCH联盟初始研究的结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Understanding the burden of antibiotic resistance globally is hindered by incomplete surveillance, particularly across low-resource settings. The Antibiotic Resistance in Communities and Hospitals (ARCH) consortium encompasses sites across 6 resource-limited settings and is intended to address these gaps. Supported by the Centers for Disease Control and Prevention, the ARCH studies seek to characterize the burden of antibiotic resistance by examining colonization prevalence at the community and hospital level and to evaluate for risk factors that are associated with colonization. In this supplement, 7 articles present results from these initial studies. Though future studies identifying and evaluating prevention strategies will be critical to mitigate spreading resistance and its impact on populations, the findings from these studies address important questions surrounding the epidemiology of antibiotic resistance.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Styczynski A, Herzig C, Luvsansharav UO, et al. Using Colonization to Understand the Burden of Antimicrobial Resistance Across Low- and Middle-Income Countries. Clin Infect Dis. 2023. PMID: 37406047. doi:10.1093/cid/ciad224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。